PROSTATE-SPECIFIC AND TUMOR-SPECIFIC TARGETING OF AN ONCOLYTIC HSV-1 AMPLICON/HELPER VIRUS FOR PROSTATE CANCER TREATMENT
$-37,503FY2010Department of the ArmyDOD
University Of British Columbia, Vancouver BC
University Of British Columbia, Vancouver BC